Cipla receives six observations from USFDA following Goa facility inspection
MM Desk
22 June, 2024
Cipla Ltd, announced on Friday (June 21) that its manufacturing facility in Goa, India, underwent
Cipla Ltd, announced on Friday (June 21) that its manufacturing facility in Goa, India, underwent
Lupin announced that the United States Food and Drug Administration (USFDA) has completed its inspection
Torrent Pharma, has announced that its manufacturing facility in Indrad, Gujarat, has received a Form
Dr Reddy’s Laboratories Ltd, a prominent pharmaceutical company based in Hyderabad, announced on Friday that
Lupin Limited has announced that the US Food and Drug Administration (FDA) concluded a pre-approval
Pharmaceutical giant Cipla Ltd disclosed on Wednesday that it has received one inspectional observation in